Biosimilar Medications and MS: What You Need To Know

Biosimilar Medications and MS: What You Need To Know

By |

Podcast: Play in new window | Download (Duration: 21:06 — 48.3MB) | Embed

Subscribe: Apple Podcasts | Spotify | iHeartRadio | Podchaser | Email | RSS | More

Biosimilar Medications and MS: What You Need To Know – Episode 155 – Transcript –

Biosimilars are not new to the medical world, but they are new to multiple sclerosis. In this episode, host Stephanie Buxhoeveden welcomes neurologist Derrick Robertson to talk about what you need to know about biosimilar medications as they come to market. Join us for this conversation, and you’ll get answers to common questions like: what is a biosimilar? What are the differences between biosimilars vs. generics? What is the biosimilar approval process? Are biosimilars safe? And what questions you should be asking your doctor.

Thank you to Sandoz for their support of this podcast episode.

 

Disclaimer: This podcast provides general educational information. Can Do MS does not endorse, promote, or recommend any product or service associated with the content of this program.

 

Comments are closed.